Sponsor or institution

Clinical trials and research at Hudson Biotech

• 8Clinical trials
• 1Country

Newest trials

All recruiting trials (8)

• MOTS-c to improve insulin sensitivity in adults with prediabetes and overweight or obesity

  This 12-week test will see if the investigational peptide MOTS-c can improve insulin sensitivity in adults with prediabetes who are overweight or have obesity.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07505745

• TB-500 (thymosin beta 4 fragment) to improve blood vessel function in people with stable atherosclerotic cardiovascular disease

  This trial will test whether TB-500 (a fragment of thymosin beta 4) is safe and can improve blood vessel function in adults aged 40–75 with stable ASCVD.

  Recruiting Phase 1/2 Hudson Biotech · Shenzhen, Guangdong · NCT07487363

• Once-weekly tirzepatide injections for adults with obesity or overweight and weight-related conditions

  This trial will see if once-weekly tirzepatide injections (5 mg, 10 mg, or 15 mg) plus a reduced-calorie diet and increased activity help adults with obesity or overweight (without diabetes) lose and keep off weight compared with placebo.

  Recruiting Phase 3 Hudson Biotech · Shenzhen, Guangdong · NCT07481747

• Tesamorelin to reduce liver fat in adults with fatty liver disease

  This trial tests whether a daily self‑injection of tesamorelin can lower liver fat over 52 weeks in adults with fatty liver disease.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07481734

• Once-weekly retatrutide injections to help reduce weight in adults with obesity or overweight

  This trial will test whether once-weekly injections of retatrutide help adults with obesity or overweight (without type 2 diabetes) lose more weight than placebo while following diet and activity advice.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07467447

• Topical GHK-Cu gel to speed healing of small skin wounds

  This test will see if applying a daily GHK‑Cu gel helps small punch‑biopsy skin wounds heal faster in healthy adults.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07437586

• Melanotan II (MT-II) plus narrowband UV-B to improve repigmentation in stable nonsegmental vitiligo

  This Phase 2 test will see if adding Melanotan II (MT-II) to standard narrowband UV-B phototherapy helps adults with stable nonsegmental vitiligo regain skin pigment.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07437560

• BPC-157 to speed healing of acute grade II hamstring strains

  This Phase 2 trial will test whether daily subcutaneous BPC-157 for 14 days helps adults 18–45 with MRI-confirmed grade II hamstring strains heal faster and return to sport sooner than placebo while following a standard rehabilitation program.

  Recruiting Phase 2 Hudson Biotech · Shenzhen, Guangdong · NCT07437547

Quick answers

How many clinical trials run by Hudson Biotech are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →